Posted: Monday, September 30, 2019
Theresa M. Medina, MD, of the University of Colorado, Denver, discusses her thoughts on the potential of immunotherapy in the treatment of patients with locally advanced or metastatic cutaneous basal cell carcinomas.
Cetuximab (Non-Melanoma Skin Cancers)
NEW Cemiplimab Combination Treatment for Solid Organ Transplant Recipients
UPDATE Cemiplimab in Cutaneous Squamous Cell Carcinoma
Cemiplimab-rwlc in Cutaneous Squamous Cell Carcinoma
American Academy of Dermatology
AIM at Skin Cancer Offers Clinician Guidance on Patient Resources and Education
Multidisciplinary Advanced Cutaneous Squamous Cell Carcinoma Care Project
